Among all treatment groups, the anti-PD-L1 followed by anti-PD-1 was the most effective combination protocol to control lung metastasis from CT26 colon cancer cells (p = 0.03) (Figure 3F). Here, PDCD1 is linked to malignant colon neoplasm.